Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal idursulfase with Elaprase in pediatric Hunter syndrome with early cognitive impairment
2013-002885-38Phase 2Completed
- Sponsor
- Takeda
- Start
- Sep 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of idursulfase in mucopolysaccharidosis type 2 (2 arms), sponsored by Takeda. Primary endpoint: Change from baseline in General Conceptual Ability score at Week 52. Started Sep 2013; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on 2013-002885-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002885-38.